Wealth Enhancement Advisory Services
ORIC icon

Wealth Enhancement Advisory Services’s Oric Pharmaceuticals ORIC Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
16,949
+5,202
+44% +$47.2K ﹤0.01% 3620
2026
Q1 		$104K Buy
+11,747
New +$133K ﹤0.01% 3310
2025
Q4 		– Sell
-10,002
Closed -$141K – 3761
2025
Q3 		$141K Buy
+10,002
New +$105K ﹤0.01% 3256

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wealth Enhancement Advisory Services's ORIC Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Oric Pharmaceuticals (ORIC) stake by 44% in Q2 2026, buying an estimated $47.2K and bringing the position to 16,949 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3620.

Wealth Enhancement Advisory Services first reported a position in ORIC in Q3 2025 and has held it in 3 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Wealth Enhancement Advisory Services held 16,949 shares of Oric Pharmaceuticals worth $184K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 5,202 Oric Pharmaceuticals shares in Q2 2026, an estimated $47.2K.
  • Oric Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3620 holding.
  • Wealth Enhancement Advisory Services first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.